1、S-1/A 1 fs12022a5_bluewatervac.htm REGISTRATION STATEMENTAs filed with the United States Securities and Exchange Commission onJanuary 6,2022.No.333-260137UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549_AMENDMENT NO.5 TOFORM S-1REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933
2、_BLUE WATER VACCINES,INC.(Exact name of registrant as specified in its charter)_Delaware283483-2262816(State or otherjurisdiction ofincorporation ororganization)(Primary StandardIndustrialClassification CodeNumber)(I.R.S.EmployerIdentification No.)201 E.Fifth Street,Suite 1900Cincinnati,Ohio 45202Te
3、lephone:(513)620-4101(Address,including zip code,and telephone number,including area code,ofregistrants principal executive offices)_Joseph Hernandezc/o Blue Water Vaccines,Inc.201 E.Fifth Street,Suite 1900Cincinnati,Ohio 45202Telephone:(513)620-4101(Name,address,including zip code,and telephone num
4、ber,including areacode,of agent for service)_Copies of all communications,including communications sent to agent forservice,should be sent to:Barry I.Grossman,Esq.Jessica Yuan,Esq.Ellenoff Grossman&Schole LLP1345 Avenue of the Americas,11thFloorNew York,New York 10105Telephone:(212)370-1300Fax:(212)
5、370-7889Mitchell Nussbaum,Esq.Angela Dowd,Esq.Lili Taheri,Esq.Loeb&Loeb LLP345 Park AvenueNew York,New York 10154Telephone:(212)407-4000Fax:(212)407-4990_Approximate date of commencement of proposed sale to the public:As soon as practicable afterthe effective date of this registration statement.If a
6、ny of the securities being registered on this Form are to be offered on a delayed orcontinuous basis pursuant to Rule 415 under the Securities Act of 1933,check the following box:If this Form is filed to register additional securities for an offering pursuant to Rule462(b)under the Securities Act,pl